{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': '34175 Ardenwood Boulevard',
 'address2': 'Suite 200',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 6.37,
 'askSize': 900,
 'averageDailyVolume10Day': 443912,
 'averageVolume': 734044,
 'averageVolume10days': 443912,
 'beta': 2.010084,
 'beta3Year': None,
 'bid': 6.34,
 'bidSize': 1400,
 'bookValue': 1.884,
 'category': None,
 'circulatingSupply': None,
 'city': 'Fremont',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 6.57,
 'dayLow': 6.23,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -5.056,
 'enterpriseToRevenue': 66.352,
 'enterpriseValue': 430890272,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 6.7734284,
 'fiftyTwoWeekHigh': 8.815,
 'fiftyTwoWeekLow': 2.1,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 57713233,
 'forwardEps': -1.08,
 'forwardPE': -5.851852,
 'fromCurrency': None,
 'fullTimeEmployees': 88,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.00653,
 'heldPercentInstitutions': 0.85955,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/ardelyx.com',
 'longBusinessSummary': 'Ardelyx, Inc., a biopharmaceutical company, develops '
                        'and sells medicines for the treatment of cardiorenal '
                        'diseases in the United States and internationally. '
                        "The company's lead product candidate is tenapanor, "
                        'which has completed Phase 3 clinical trial for the '
                        'treatment of patients with irritable bowel syndrome '
                        'with constipation, as well as in Phase 3 clinical '
                        'trial for the treatment of hyperphosphatemia in '
                        'end-stage renal disease patients on dialysis. It also '
                        'develops RDX013, a small molecule potassium '
                        'secretagogue program for the treatment of patients '
                        'with hyperkalemia. The company was formerly known as '
                        'Nteryx, Inc. and changed its name to Ardelyx, Inc. in '
                        'June 2008. Ardelyx, Inc. was founded in 2007 and is '
                        'headquartered in Fremont, California.',
 'longName': 'Ardelyx, Inc.',
 'market': 'us_market',
 'marketCap': 562838976,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_58915635',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -91169000,
 'nextFiscalYearEnd': 1640908800,
 'open': 6.54,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.21,
 'phone': '510 745 1700',
 'previousClose': 6.57,
 'priceHint': 2,
 'priceToBook': 3.354565,
 'priceToSalesTrailing12Months': 86.670616,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 6.57,
 'regularMarketDayLow': 6.23,
 'regularMarketOpen': 6.54,
 'regularMarketPreviousClose': 6.57,
 'regularMarketPrice': 6.54,
 'regularMarketVolume': 480958,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 89056800,
 'sharesPercentSharesOut': 0.061100002,
 'sharesShort': 5443411,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2918300,
 'shortName': 'Ardelyx, Inc.',
 'shortPercentOfFloat': 0.0752,
 'shortRatio': 5.96,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ARDX',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.283,
 'twoHundredDayAverage': 6.842878,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '419f5034-7b70-3f95-acd4-15f78343e65d',
 'volume': 480958,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.ardelyx.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94555'}